Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment
INTERVENTIONAL
Inicio: 1 de sept de 2000
ID: NCT00268216
Completado
Fase 4
ClinicalTrials.gov
Bacillus Clausii in the Treatment of Acute Community-acquired Diarrhea Among Latin American Children (cadiLAc)
INTERVENTIONAL
Inicio: 1 de jul de 2014
ID: NCT02169817
Completado
Fase 3
ClinicalTrials.gov
A Randomized Placebo Controlled Study Of OSI-774 (TARCEVA) Plus Gemcitabine In Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer
INTERVENTIONAL
Inicio: 29 de oct de 2001
ID: NCT00026338
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Open-label, Phase II Clinical Trial of Relatlimab (Anti-LAG-3) and Nivolumab in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy as First-Line Treatment in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
INTERVENTIONAL
Inicio: 16 de oct de 2018
ID: NCT03662659
Completado
Fase 3
ClinicalTrials.gov
HZC102871: A 52-week Efficacy and Safety Study to Compare the Effect of Three Dosage Strengths of Fluticasone Furoate/GW642444 Inhalation Powder With GW642444 on the Annual Rate of Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 25 de sept de 2009
ID: NCT01009463
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double-blind, Placebo-controlled Study of Sorafenib as Adjuvant Treatment for Hepatocellular Carcinoma After Surgical Resection or Local Ablation.
INTERVENTIONAL
Inicio: 15 de ago de 2008
ID: NCT00692770
Completado
Fase 3
ClinicalTrials.gov
Phase III, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Have Been Previously Exposed to TNF Inhibitors
INTERVENTIONAL
Inicio: 21 de may de 2014
ID: NCT02100696
Activo, no recluta
ClinicalTrials.gov
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)
OBSERVATIONAL
Inicio: 21 de nov de 2022
ID: NCT05476926
Terminado
Fase 2
ClinicalTrials.gov
Open-label, Multi-cohort, Phase 2 Trial, Evaluating the Efficacy and Safety of Tusamitamab Ravtansine (SAR408701) Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
INTERVENTIONAL
Inicio: 29 de mar de 2021
ID: NCT04659603
Reclutando
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase III Trial Evaluating Long-term Efficacy and Safety of Survodutide Weekly Injections in Adult Participants With Noncirrhotic Non-alcoholic Steatohepatitis/Metabolic Dysfunction-associated Steatohepatitis (NASH/MASH) and (F2) - (F3) Stage of Liver Fibrosis
INTERVENTIONAL
Inicio: 17 de sept de 2024
ID: NCT06632444
Completado
Fase 3
ClinicalTrials.gov
DB2114930: A Randomized, Multi-center, Double-blind, Double-dummy, Parallel Group Study to Evaluate the Efficacy and Safety of Umeclidinium/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With COPD
INTERVENTIONAL
Inicio: 1 de mar de 2013
ID: NCT01817764
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes
INTERVENTIONAL
Inicio: 15 de oct de 2025
ID: NCT07165028
Completado
ClinicalTrials.gov
A Prospective Epidemiological Study of Pregnancy Outcomes and of Events of Interest in Pregnant Women, Neonates and Infants (PEPNI)
INTERVENTIONAL
Inicio: 30 de may de 2019
ID: NCT03614676
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Placebo-controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00105443
Reclutando
Fase 4
ClinicalTrials.gov
Non Randomized, Multicenter, Prospective Pediatric Hodgkin Lymphoma Treatment Trial Stratified According to Initial Risk Factors and Response to Chemotherapy, Reduced Cumulative Doses of Antineoplastic Agents and Radiotherapy.
INTERVENTIONAL
Inicio: 6 de oct de 2017
ID: NCT03500133
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
INTERVENTIONAL
Inicio: 6 de feb de 2019
ID: NCT03627091
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
INTERVENTIONAL
Inicio: 5 de dic de 2017
ID: NCT03259308
Completado
Fase 2
ClinicalTrials.gov
A 24-month Randomized Multicenter Study Evaluating Efficacy, Safety, Tolerability and Pharmacokinetics of Sotrastaurin and Tacrolimus vs. a Tacrolimus/Mycophenolate Mofetil-based Control Regimen in de Novo Liver Transplant Recipients
INTERVENTIONAL
Inicio: 1 de abr de 2010
ID: NCT01128335
Reclutando
ClinicalTrials.gov
Advanced Wireless Sensors for Neonatal Care in the Delivery Room: the AWARD Prospective Multicenter International Study
INTERVENTIONAL
Inicio: 8 de abr de 2025
ID: NCT06693817
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
INTERVENTIONAL
Inicio: 17 de sept de 2024
ID: NCT06497504
Anterior
1
...
13
14
15
...
434
Siguiente
Filtros